Heat-shock proteins as powerful weapons in vaccine development.
about
Mini-chaperones: potential immuno-stimulators in vaccine designImmunogenicity and protective efficacy of recombinant M2e.Hsp70c (Hsp70(359-610)) fusion protein against influenza virus infection in mice.Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.Surface-associated Hsp60 chaperonin of Leptospira interrogans serovar Autumnalis N2 strain as an immunoreactive protein.Strategies for cancer vaccine development.Hyperthermia stimulates HIV-1 replicationTranslating tumor antigens into cancer vaccinesTumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner.Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablationDetrimental Effect of Fungal 60-kDa Heat Shock Protein on Experimental Paracoccidioides brasiliensis Infection.Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineRecombinant Nonstructural 3 Protein, rNS3, of Hepatitis C Virus Along With Recombinant GP96 Induce IL-12, TNFα and α5integrin Expression in Antigen Presenting Cells.Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept.The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.Hsp70 in cancer: back to the future.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.DNAhsp65 Vaccine as Therapy against Paracoccidioidomycosis.Increased immunogenicity is an integral part of the heat shock response following renal ischemia.The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.Cloning and expression pattern of a heat shock cognate protein 70 gene in ticks (Haemaphysalis flava).Ts-Hsp70 induces protective immunity against Trichinella spiralis infection in mouse by activating dendritic cells through TLR2 and TLR4.A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.Enhancement of potent immune responses to HPV16 E7 antigen by using different vaccine modalities.
P2860
Q27005634-50482B74-7E61-49E8-9F04-887DA8DB9FDBQ30366089-ED017DBE-D26A-4C54-92F3-D6AF7E1E53D5Q33577507-895F359B-48A3-466D-83B9-25E34AD65276Q33863787-506C1980-8C55-475D-A737-E01A8A6FC564Q34038338-76D1B296-CDF2-43D4-9747-A03B0B0684EEQ34341364-19C33866-CD62-4502-9312-1D04049FE69EQ34484042-DD66927F-5EE0-4DB2-8F76-B879B36B0988Q34551535-7B980CFF-F8A9-4683-8238-D494C905601CQ34852383-840375DF-0B8F-48ED-BCE4-98E1F85B4EFCQ35164953-AC6BBB04-D4BE-46F0-936F-2211B921E8BDQ36123880-A7D580ED-73D1-4220-A6FC-0D393D4E66ACQ36391595-30AD4E3C-50F6-4E2F-B80A-977397AE398FQ36702887-C6002618-5EC1-4FA7-A6F8-74B49A72BE8AQ37158810-568E29AA-F374-454C-A32C-7AD713E676F4Q37310612-4E8589FA-49B9-4C44-A7AD-309BA791BB70Q37908142-87282D80-7D62-4666-9FA2-A19E75132E5AQ38109551-DCDE55E1-6444-41CE-BFE1-6173779768E8Q38263003-85786231-D8C5-4823-9C97-33D0EE24EBDAQ38620773-D8B76A6F-BC80-42C6-A456-CC134A03A2A4Q38751464-98E74CA6-DC7A-44F0-B5C4-876A19446272Q39396051-87906BED-E38F-4EE5-8440-4B8B2124EA5FQ39425915-0D629E27-21B9-431C-A796-A2FE6935FADAQ39474019-1B0C330C-520E-4BF9-A87F-EDB0DFA92F1FQ40363195-A8D6E5E6-0D82-41AF-9C7E-2CD8A07E1F12Q45888118-69B0C64F-E76F-4EA4-BC0A-858FD4E41577Q47776368-3400970F-3FDD-4833-BDD2-4C4D514FDE74Q54206838-FDCB714A-F7CD-4E2D-A29C-41C80ECC5A81Q54377524-293D5E18-1A7D-4BEC-BA86-9DDAE740BD66Q55463181-A7732BEB-926E-438B-A7AA-35F57672AAAD
P2860
Heat-shock proteins as powerful weapons in vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heat-shock proteins as powerful weapons in vaccine development.
@en
Heat-shock proteins as powerful weapons in vaccine development.
@nl
type
label
Heat-shock proteins as powerful weapons in vaccine development.
@en
Heat-shock proteins as powerful weapons in vaccine development.
@nl
prefLabel
Heat-shock proteins as powerful weapons in vaccine development.
@en
Heat-shock proteins as powerful weapons in vaccine development.
@nl
P2860
P1476
Heat-shock proteins as powerful weapons in vaccine development.
@en
P2093
Azam Bolhassani
Sima Rafati
P2860
P304
P356
10.1586/14760584.7.8.1185
P577
2008-10-01T00:00:00Z